Imunon (IMNN) Other Accumulated Expenses (2010 - 2024)
Imunon's (IMNN) quarterly Other Accumulated Expenses came in at $20000.0 in Q4 2024, little changed YoY from $20000.0 in Q1 2024, and little changed on a QoQ basis from $20000.0 in Q2 2024.
Imunon (IMNN) Other Accumulated Expenses (2010 - 2024) Analysis & Trends
Imunon (IMNN) has 15 years of Other Accumulated Expenses data on file, last reported at $20000.0 in Q4 2024.
- Quarterly Other Accumulated Expenses changed 0.0% year-over-year to $20000.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $20000.0 (changed 0.0% YoY) and the FY2024 annual result came in at $20000.0, changed 0.0% from the prior year.
- Other Accumulated Expenses held at $20000.0 in Q4 2024, from $20000.0 in the prior quarter.
- In the past five years, Other Accumulated Expenses ranged from a high of $205313.0 in Q4 2022 to a low of $19411.0 in Q1 2020.
- A 5-year average of $35286.2 and a median of $20000.0 in 2023 frame the typical range for Other Accumulated Expenses.
- Annual changes were most pronounced in 2022 — Other Accumulated Expenses soared 553.61% — and 2023, when it tumbled 90.26%.
- Tracing IMNN's Other Accumulated Expenses over 5 years: stood at $19411.0 in 2020, then jumped by 61.83% to $31412.0 in 2021, then soared by 553.61% to $205313.0 in 2022, then plunged by 90.26% to $20000.0 in 2023, then changed by 0.0% to $20000.0 in 2024.
- The last three Other Accumulated Expenses figures came in at $20000.0 (Q4 2024), $20000.0 (Q2 2024), and $20000.0 (Q1 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Imunon | 8.42 Mn | 8.42 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 20,000.00 |
| Jun 30, 2024 | 20,000.00 |
| Mar 31, 2024 | 20,000.00 |
| Dec 31, 2023 | 20,000.00 |
| Sep 30, 2023 | 20,000.00 |
| Jun 30, 2023 | 30,000.00 |
| Mar 31, 2023 | 97,600.00 |
| Dec 31, 2022 | 205,313.00 |
| Sep 30, 2022 | 19,412.00 |
| Jun 30, 2022 | 19,412.00 |
| Mar 31, 2022 | 31,412.00 |
| Dec 31, 2021 | 31,412.00 |
| Sep 30, 2021 | 19,411.00 |
| Jun 30, 2021 | 19,411.00 |
| Mar 31, 2021 | 19,411.00 |
| Dec 31, 2020 | 19,411.00 |
| Sep 30, 2020 | 19,411.00 |
| Jun 30, 2020 | 19,411.00 |
| Mar 31, 2020 | 19,411.00 |
| Dec 31, 2019 | 19,411.00 |